Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

NCT00053807 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

NETWORK

Sponsor class

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: recombinant interferon alfa
DRUG: fluorouracil
PROCEDURE: adjuvant therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]